Houot R - Search Results

1

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.

Irish JM, Myklebust JH, Alizadeh AA, Houot R, Sharman JP, Czerwinski DK, Nolan GP, Levy R. Irish JM, et al. Among authors: houot r. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):12747-54. doi: 10.1073/pnas.1002057107. Epub 2010 Jun 11. Proc Natl Acad Sci U S A. 2010. PMID: 20543139 Free PMC article.

2

T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy.

Houot R, Levy R. Houot R, et al. Blood. 2009 Apr 9;113(15):3546-52. doi: 10.1182/blood-2008-07-170274. Epub 2008 Oct 21. Blood. 2009. PMID: 18941113 Free PMC article.

3

Vaccines for lymphomas: idiotype vaccines and beyond.

Houot R, Levy R. Houot R, et al. Blood Rev. 2009 May;23(3):137-42. doi: 10.1016/j.blre.2008.09.001. Epub 2008 Oct 31. Blood Rev. 2009. PMID: 18951668 Review.

4

Idiotype vaccination for lymphoma: moving towards optimisation.

Houot R, Levy R. Houot R, et al. Leuk Lymphoma. 2009 Jan;50(1):1-2. doi: 10.1080/10428190802517807. Leuk Lymphoma. 2009. PMID: 19172492 No abstract available.

5

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion.

Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R. Houot R, et al. Blood. 2009 Oct 15;114(16):3431-8. doi: 10.1182/blood-2009-05-223958. Epub 2009 Jul 29. Blood. 2009. PMID: 19641184 Free PMC article.

6

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.

Kohrt HE, Houot R, Goldstein MJ, Weiskopf K, Alizadeh AA, Brody J, Müller A, Pachynski R, Czerwinski D, Coutre S, Chao MP, Chen L, Tedder TF, Levy R. Kohrt HE, et al. Among authors: houot r. Blood. 2011 Feb 24;117(8):2423-32. doi: 10.1182/blood-2010-08-301945. Epub 2010 Dec 30. Blood. 2011. PMID: 21193697 Free PMC article. Retracted.

7

Immunomodulating antibodies and drugs for the treatment of hematological malignancies.

Houot R, Kohrt H, Goldstein MJ, Levy R. Houot R, et al. Cancer Metastasis Rev. 2011 Mar;30(1):97-109. doi: 10.1007/s10555-011-9274-3. Cancer Metastasis Rev. 2011. PMID: 21271352 Review.

8

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.

Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, Lossos IS, Levy R. Alizadeh AA, et al. Among authors: houot r. Blood. 2011 Aug 4;118(5):1350-8. doi: 10.1182/blood-2011-03-345272. Epub 2011 Jun 13. Blood. 2011. PMID: 21670469 Free PMC article.

9

Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy.

Houot R, Kohrt HE, Marabelle A, Levy R. Houot R, et al. Trends Immunol. 2011 Nov;32(11):510-6. doi: 10.1016/j.it.2011.07.003. Epub 2011 Sep 8. Trends Immunol. 2011. PMID: 21907000

10

Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells.

Goldstein MJ, Kohrt HE, Houot R, Varghese B, Lin JT, Swanson E, Levy R. Goldstein MJ, et al. Among authors: houot r. Cancer Res. 2012 Mar 1;72(5):1239-47. doi: 10.1158/0008-5472.CAN-11-3375. Epub 2012 Jan 9. Cancer Res. 2012. PMID: 22232735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page